Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms
Completed
Conditions studied: Congestive Heart Failure, Sudden Cardiac Death, Arrhythmia, Cardiomyopathies
In brief
The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: * to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and * to predict progression of heart failure in patients with ICD.
Key facts
- Study ID
- NCT00916435
- Run by
- Johns Hopkins University
- People needed
- 630
- Starts
- 2005-03-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2015-04-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- history of acute MI at least 4 weeks old
- non-ischemic LV dysfunction for at least 9 months
- who have an EF < or = to 35%
- who was resuscitated from sudden cardiac arrest (ventricular tachyarrhythmia)
- undergone implantation of an FDA-approved ICD for primary or secondary prevention of SCD
You may not qualify if…
- inability or unwillingness to provide valid informed consent
- pregnancy
- any condition other than cardiac disease that was associated with a high likelihood of death during 1 year after enrollment
Where it is running
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Washington University School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.